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Abstract. Dichotomous diagnostic tests are widely used to detect the presence or absence of a biomedical
condition of interest. A rigorous evaluation of the accuracy of a diagnostic test is critical to determine its
practical value. Performance measures, such as the sensitivity and specificity of the test, should be estimated
by comparison with a gold standard. Since an error-free reference test is frequently missing, approaches
based on available imperfect diagnostic tests are used, namely: comparisons with an imperfect gold standard
or with a composite reference standard, discrepant analysis, and latent class models.
In this work, we compare these methods using a theoretical approach based on analytical expressions for
the deviations between the sensitivity and specificity according to each method, and the corresponding true
values. We explore the impact on the deviations of varying conditions: tests sensitivities and specificities,
prevalence of the condition and local dependence between the tests. An R interactive graphical application
is made available for the visualisation of the outcomes. Based on our findings, we discuss the methods
validity and potential usefulness.
1. Introduction
Diagnostic test accuracy studies are crucial to determine the test’s ability to discriminate between the
presence or absence of a certain target condition (such as disease, infection or parasite) and thus to establish
the practical value of a new diagnostic test. Two commonly used diagnostic test performance measures are
the sensitivity (Se), the probability that the test result is positive given that the subject has the target
condition, and the specificity (Sp), the probability that the test result is negative given that the subject does
not have the target condition. Ideally, these measures would be estimated by comparison with a perfect
reference test or gold standard (GS), an error-free diagnostic procedure with Se = Sp = 1. A GS would
determine with certainty the status of the condition of interest in the individual and thereby enable the
estimation of any diagnostic test performance measures.
However, the ideal situation of having a perfect reference test is often impossible, due to budget, ethical
or technical restrictions, or even because there is no GS for the target condition. Begg [1] argues that
more accurate tests are often more expensive and/or invasive, disadvantages which may hinder their use.
In practice, it is rare for a reference standard to be completely error-free [2], as almost all tests are subject
to potential error, even biopsy or autopsy [1]. Therefore, the definitive diagnosis required for the correct
accuracy estimation of a new diagnostic test may actually be impossible to obtain.
The performance evaluation process that new tests undergo before being introduced into practice should
be sound and rigorous to produce trustworthy conclusions [3, 4]. Methodological flaws in diagnostic studies
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can lead to biased estimates of the index test accuracy. Such erroneous findings can have a considerable
impact in practice [5], since diagnostic tests deliver key information for decision-making in the biomedical
context.
Diverse sources of bias may affect diagnostic test accuracy studies and distort the estimated accuracy of
a diagnostic test [6]. In our work we will only focus on the bias arising from evaluating the accuracy of a
diagnostic test when a GS is missing. Our aim is to gain insight into alternative methods used in this context
and offer guidance towards an adequate choice of test performance evaluation method. The need for further
developments and methodological research regarding this topic has been emphasized by [7] and [8].
Authors in [7, 9–11] provide a broad overview on the variety of methods found in the literature to address
the problem of evaluating the accuracy of a diagnostic test in the absence of a GS. We address in the present
work some of the most widespread and undemanding among these methods: imperfect gold standard (IGS),
composite reference standard (CRS), with the ”and” rule and the ”or” rule, discrepant analysis (DA) and
latent class models (LCM), all of which rely on available imperfect diagnostic tests to estimate the index
test accuracy.
When a GS is missing, a straightforward approach to evaluate the performance of a new test consists of
adopting as reference an imperfect test which is perceived as the best available test for the target condition.
Since this test, named imperfect gold standard, is not error-free, it will potentially misclassify some subjects
regarding the target condition and thus bias the estimates of the performance measures of the index test.
This type of bias, called imperfect gold standard bias [12]1, has been investigated by several authors over
the years [e.g., 2, 12, 13, 15–18].
As an alternative to using a single imperfect reference, multiple imperfect tests may be combined into a
composite reference standard, according to a fixed rule [12, 19]. The rational behind this approach is that
the CRS will be more accurate in terms of Se or Sp than each component test individually. Therefore, the
bias that would potentially affect the estimates of the index test accuracy measures, if a single diagnostic test
was deemed as an IGS, should be partly reduced by using the CRS. Generally, there is a trade-off between
Se and Sp of the CRS when compared to the individual component tests. Indeed, the fixed rule used to
combine the tests into a CRS may improve the Se but worsen the Sp, or vice-versa. This approach has the
merit of incorporating prior available information about the tests, since the rule adopted to combine them
should derive from previous knowledge of the tests.
Discrepant analysis is an approach that aims to overcome the misclassification errors due to the use of
an IGS. In DA, the observations for which the new test and the IGS disagree are reassessed by a second
test, called resolver test, which may even be a GS. The problems associated with DA have been largely
discussed in the literature and, with rare exceptions [20], this method has been strongly criticized and its
use discouraged [21–27]. These authors argue that, even if DA is an intuitive method, in fact it is inherently
biased, overestimating test accuracy measures in most situations, and unscientific, because the new test
is used to determine the true target condition status, presumably leading to incorporation bias [6]. In
agreement with these claims, the US Food and Drug Administration also states that DA is an inappropriate
method to estimate a diagnostic test Se and Sp [28].
Despite all the criticism, we include DA in our study, in order to rigorously evaluate its performance,
since this method relies on a very intuitive and appealing strategy, which in fact is used in other fields of
study. We anticipate that DA surprisingly arises as the preferable method in some scenarios.
In the context of diagnostic test studies, a widely used latent class model admits multiple binary manifest
variables, that express the results of imperfect diagnostic tests, and an underlying binary latent variable,
which defines two latent classes, that represent the presence or absence of a target condition. This two-latent
class model is used to estimate the tests accuracy measures and the prevalence of the condition [11, 29–31].
1Other designations can be found in the literature, such as reference test bias [13], imperfect reference standard bias [6] or
imperfect reference bias [14].
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The simplest latent class models presume conditional independence between the tests results, i.e., manifest
variables expressing the tests outcomes are independent for fixed values of the latent variable. The so-called
Hypothesis of Conditional or local Independence (HCI) is a rather questionable assumption in many practical
situations [2, 18, 31, 32]. Criticisms have been directed towards LCM regarding the difficulty in evaluating
the basic assumption of conditional independence [33] and the bias resulting from the use of LCM when this
assumption does not hold [e.g., 11, 19, 30, 31, 34].
LCM that relax the conditional independence assumption have been proposed in the literature, admitting
either maximum likelihood estimation or bayesian inference [for example, 34–36], but are not addressed in
this paper. Albert and Dodd [30] have shown that LCM with different local dependence structures can
adjust equally well to the data, but lead to different accuracy estimates. Identifiability problems have also
been pointed out [37, 38], as a consequence of the large number of parameters to estimate.
As mentioned earlier, IGS, CRS (with the ”and” rule and the ”or” rule), DA and LCM are the methods
addressed in this work. We derive algebraic expressions for the deviations between each method’s Se and
Sp, and the corresponding true values, to evaluate and compare the methods. This theoretical approach,
which removes the confounding effect of the sampling scheme, aims to provide a better understanding of the
evaluation approaches under study, by clarifying the magnitude and direction of the deviations from the true
values of Se and Sp, in view of varying factors: the tests Se and Sp, the prevalence of the target condition
and the magnitude of the conditional dependence between the tests.
The theoretical unified approach we adopt to jointly investigate the aforementioned methods aims to
gather comparable and consistent findings on the methods to give insight into their comparative value, and
thus provide recommendations on their use in practical situations.
An interactive graphical web application, developed using the R Shiny package [39], is made available along
with this article, allowing users to visualise how the investigated methods Se and Sp theoretical deviations
vary under different conditions. By making it possible to experiment distinct settings, and mimic real cases
if needed, this application intends to make the theoretical findings more tangible and comprehensible, and
hence useful in real diagnostic accuracy studies.
The paper is structured as follows. We start with Section 1, which introduces the subject being studied, as
well as our approach to the problem, and gives a brief description of the accuracy evaluation methods under
comparison. Section 2 presents the notation and the setup adopted in our study. The following sections
present the Se and Sp analytical expressions derived for the different methods: the IGS is addressed in
Section 3, CRS in Section 4, DA in Section 5, a unified approach between the previous methods in Section 6,
and finally LCM in Section 7. Section 8 reports restrictions imposed on the parameters that model local
dependence. Based on an R Shiny application we developed to interactively visualise the outcomes of the
theoretical expressions, we present a practical application in Section 9. We conclude with Section 10, which
states final remarks and directions for future work.
2. Notation and setup
2.1. Notation. Let us admit a binary variable, Y , whose categories {0, 1} indicate the presence or absence
of a certain condition of interest (e.g., disease, infection or parasite). Y takes the value 1 if the condition is
present and 0 otherwise. Moreover, let us define η = P (Y = 1), the prevalence of the condition of interest,
i.e., the proportion of individuals with the condition in the population.
Suppose that X = (X1, ..., Xp)
T is a vector of p binary variables that express the results of p dichotomous
diagnostic tests. Xi takes the value 1 if the i-th test is positive, and 0 otherwise (i = 1, ..., p). We define Se
and Sp of the i-th test as
(1) SeXi = P (Xi = 1|Y = 1) and SpXi = P (Xi = 0|Y = 0).
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The joint probability of Xi and Xj is given by
P (Xi = xi, Xj = xj) = ηP (Xi = xi, Xj = xj |Y = 1)
+(1− η)P (Xi = xi, Xj = xj |Y = 0),(2)
where xi, xj = 0, 1, i 6= j, and i, j = 1, ..., p.
And the joint probability of Xi and Xj conditional on the category {Y = y} emerges as
P (Xi = xi, Xj = xj |Y = y) = P (Xi = xi|Y = y)P (Xj = xj |Y = y)
+(−1)xi−xjcov(Xi, Xj |Y = y).(3)
Suppose that Xi and Xj are independent conditional on the category of Y , expressed as Xi⊥⊥ Xj | Y = y,
where y = 0, 1, i 6= j, and i, j = 1, ..., p. That is to say, HCI is valid. Accordingly, cov(Xi, Xj |Y = y) = 0.
Hence, (3) simplifies into
P (Xi = xi, Xj = xj |Y = y) = P (Xi = xi|Y = y)P (Xj = xj |Y = y).(4)
Let us define the Youden’s index [40], denoted by J, a statistic that measures the performance of diagnostic
tests, which is noticeable in some of the expressions presented further ahead in this document. For the i-th
test, it is defined as
JXi = SeXi + SpXi − 1.(5)
The Youden’s index possible values range between -1 and 1. The index takes the value 1 in face of a perfect
diagnostic test, with SeXi = SpXi = 1, and the value of -1 for a test with null Se and Sp, SeXi = SpXi = 0.
Moreover, the Youden’s index has the value zero when the probability of a positive (negative) test result is the
same regardless of the presence or absence of the target condition. Naturally, a test with such characteristics
is useless. In fact, for a diagnostic test to be useful in the diagnostic process, it should verify SeXi+SpXi > 1,
which can also be expressed as JXi > 0. These conditions mean that it is more likely to observe a positive
(negative) test result given a true positive (negative) subject than otherwise.
2.2. Setup. In this paper, we adopt an hypothetical setup to assess and compare the potential of using the
aforementioned alternative methods of diagnostic test evaluation. We suppose that we want to evaluate the
accuracy of a new diagnostic test for a certain condition, X , in the absence of a GS. We also assume that
only two imperfect diagnostic tests for the same condition, Z1 and Z2, are available, and the true state of
the condition, Y , cannot be observed.
In our setup, we admit the straightforward HCI assumption, according to which X , Z1, and Z2 are
conditionally independent given the true state of the target condition, Y :
X⊥⊥ Z1 | Y = y, X⊥⊥ Z2 | Y = y, and Z1⊥⊥ Z2 | Y = y, with y = 0, 1.(6)
Additionally, since the HCI is not a realistic assumption in many practical situations, we also study,
without loss of generality, a dependence structure which accommodates local dependence between the new
test X and the IGS Z1, while the HCI is presumed valid for the remaining pairs of tests. To summarise,
according to this dependence structure, we have
X 6⊥⊥ Z1 | Y = y, X⊥⊥ Z2 | Y = y, and Z1⊥⊥ Z2 | Y = y, with y = 0, 1.(7)
Given the conditional joint probability of the tests in (3), and denoting ξ = cov(X,Z1|Y = 1) and
ǫ = cov(X,Z1|Y = 0), under the dependence structure defined by (7), we have:
P (X = x, Z1 = z1|Y = 1) = P (X = x|Y = 1)P (Z1 = z1|Y = 1) + (−1)x−z1ξ,(8)
P (X = x, Z1 = z1|Y = 0) = P (X = x|Y = 0)P (Z1 = z1|Y = 0) + (−1)x−z1ε.
It follows that the HCI case in (6) is a special case of (8) with ξ = ε = 0.
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For simplicity reasons, we restricted the local dependencies in our setup to (7). However, other structures
of local dependence among the diagnostic tests are possible, for which developments similar to the ones
presented in this paper can be formulated.
Much of the literature on local dependence between diagnostic tests merely investigates positive depen-
dence, based on the claim that it is biologically more plausible than negative dependence [e.g., 36, 41].
This type of dependence is conceivable, for instance, between diagnostic tests with a similar biological basis
[34, 42], or between tests that more easily detect severe cases than mild or weak ones, leading to concordant
true positive and false negative outcomes, and thus to positive dependence in the class of subjects with the
disease [2, 31]. Nevertheless, negative conditional dependence may also be reasonable [2], as when diagnos-
tic tests identify different subgroups of subjects with the condition, potentially leading to discordant true
positive and false negative results, i.e, local negative dependence [42]. In view of this, in our setup, both
positive and negative conditional dependence are anticipated.
We present theoretical expressions for the deviations between each method accuracy measures (Se and
Sp) of test X and the corresponding true values.
Let SeX be the true sensitivity of X and Se
M
X the theoretical expression for the sensitivity of X determined
by the method M under the assumption of HCI, which changes to SeMX under the dependence structure defined
in (7).
The deviation between SeMX and SeX is given by
(9) ∆SeM = SeMX − SeX ,
and the equivalent expression under the violation of HCI according to (7) is
(10) ∆SeM = SeMX − SeX .
Similar notation is used for specificity: ∆SpM = SpMX−SpX , under HCI, and ∆SpM = SpMX−SpX , otherwise.
We also remark that the approach we undertake could be extended to include other diagnostic accuracy
measures. In fact, analogous theoretical expressions to the ones obtained for Se and Sp could be derived
for measures such as positive and negative predictive value (PPV and NPV, respectively). PPV (NPV) is
defined as the probability that the subject is a true positive (negative) given that the test result is positive
(negative).
Each method under scrutiny and corresponding deviations are presented and deduced in the next sections.
3. Imperfect gold standard
We start by the IGS, a rather straightforward method, in which an imperfect test is used as a reference.
Suppose that X is the test under study for which we aim to estimate the performance measures by
comparison with an IGS. Take Z1 as such an IGS, characterized by
P (Z1 = 1) = ηSeZ1 + (1− η)
(
1− SpZ1
)
.(11)
The Se and Sp of X by comparison with the IGS Z1 are defined as
SeIGSX = P (X = 1|Z1 = 1),(12)
SpIGSX = P (X = 0|Z1 = 0).(13)
SeIGSX and Sp
IGS
X can be expressed as functions of the characteristics of the tests and the prevalence. For
the Se, under the HCI, we have
SeIGSX =
ηSeXSeZ1 + (1− η)(1 − SpX)(1 − SpZ1)
P (Z1 = 1)
.(14)
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Hence, the deviation emerges as
∆SeIGS = − (1− η)(1 − SpZ1)(SeX + SpX − 1)
P (Z1 = 1)
= − (1− η)(1 − SpZ1)JX
P (Z1 = 1)
.(15)
It follows that ∆SeIGS is non-positive, since we assume that JX > 0, or else X would be a useless test.
Given that both JX = 0 and η = 1 are unreasonable conditions, ∆Se
IGS is null only when the IGS Z1 has
perfect specificity, i.e., SpZ1 = 1. Besides this particular case, in which unbiased Se estimates could be
obtained, in most practical situations, using an IGS under HCI would lead to Se underestimation.
When the HCI is violated according to the dependence structure (7),
SeIGSX = Se
IGS
X +
ηξ + (1− η)ε
P (Z1 = 1)
(16)
and the Se deviation is given by
∆SeIGS = ∆SeIGS +
ηξ + (1− η)ε
P (Z1 = 1)
.(17)
These two expressions, (16) and (17), are generalizations of the basic HCI ones, (14) and (15), respectively,
in which a term expressing the conditional dependence is added to the HCI expressions, assuming positive
or negative values depending on ξ and ε.
Regarding the specificity, in the simpler HCI case, we have
SpIGSX =
η(1− SeX)(1 − SeZ1) + (1 − η)SpXSpZ1
P (Z1 = 0)
,(18)
where
P (Z1 = 0) = 1− P (Z1 = 1)(19)
Hence, the deviation is
∆SpIGS = −η(1− SeZ1)(SeX + SpX − 1)
P (Z1 = 0)
(20)
= −η(1− SeZ1)JX
P (Z1 = 0)
.
Accordingly, ∆SpIGS is also non-positive, assuming JX > 0. The null deviation occurs when the IGS, Z1,
has perfect Se, that is, SeZ1 = 1. Additionally, ∆Sp
IGS = 0 if JX = 0 or if η = 0, which are both unlikely,
since the former would indicate a worthless index test, and the latter a null prevalence.
In the case of HCI violation, the specificty emerges as
SpIGSX = Sp
IGS
X +
ηξ + (1− η)ε
P (Z1 = 0)
,(21)
with the corresponding deviation as
∆SpIGS = ∆SpIGS +
ηξ + (1− η)ε
P (Z1 = 0)
.(22)
It follows from (17) and (22) that the Se and Sp deviations under the HCI violation are composed
of two terms: a first one reflecting the method’s imperfection, shared with the HCI case, and a second
term quantifying the local dependence effects. The first term should contribute to Se/Sp underestimation,
except for a few particular cases of unbiased estimation, while the second could lead either to under or
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overestimation, depending on the local dependence. Hence the two effects contribute in opposite directions
when the local dependence term is positive.
4. Composite Reference Standard
The chosen reference standard is crucial for obtaining reliable estimates of the index test accuracy from
its comparison against the reference. We will now address the use as a reference of a CRS obtained from
the combination of two imperfect tests according to a fixed rule. Previous information available on the tests
should support the choice of rule to combine the tests. We will address two rules that can be used to combine
two diagnostic tests: the ”and” rule, in which a positive outcome emerges if both component tests indicate
a positive result, and the ”or” rule, in which a positive result occurs if any of the two tests is positive.
The bias of the index test accuracy estimates associated with the use of a CRS under the ”or” rule has
been addressed in works such as [19], [12] and [43], the latter of which also studies the CRS with the ”and”
rule.
Besides the combination of imperfect tests to form a CRS that we focus on this article, others combinations
can be found in the literature. As an example, [44] assessed a different method called PISA, used in
recent years to evaluate nucleid acid amplification tests for detecting Chlamydia tractomatis and Neisseria
gonorrhea.
4.1. Composite Reference Standard - “and” rule. Let ZCRS A be a binary variable that expresses the
results of combining two diagnostic tests according to the ”and” rule. Hence ZCRS A is positive if both tests
are positive, and negative otherwise, i.e., if any of the tests is negative,
(23) ZCRS A =
{
1, if (Z1 = 1 ∧ Z2 = 1)
0, if (Z1 = 0 ∨ Z2 = 0).
Accordingly, we can define the probabilities
P (ZCRS A = 1) = ηSeZ1SeZ2 + (1 − η)(1− SpZ1)(1− SpZ2) and(24)
P (ZCRS A = 0) = 1− P (ZCRS A = 1),
which remain unchanged whether under the HCI or the dependence structure in (7), because Z1 and Z2 are
conditionally independent in both cases.
Under the HCI, the sensitivity arises as
SeCRS AX =
ηSeXSeZ1SeZ2 + (1− η)(1 − SpX)(1 − SpZ1)(1− SpZ2)
P (ZCRS A = 1)
,(25)
and the sensitivity deviation as
∆SeCRS A = − (1− η)(1 − SpZ1)(1− SpZ2)(SeX + SpX − 1)
P (ZCRS A = 1)
(26)
= − (1− η)(1 − SpZ1)(1− SpZ2)JX
P (ZCRS A = 1)
.
Admitting the dependence structure described in (7), where X 6⊥⊥ Z1 | Y = y, with y = 0, 1, we derive
SeCRS AX = Se
CRS A
X +
ηSeZ2ξ + (1− η)(1 − SpZ2)ε
P (ZCRS A = 1)
.(27)
The Se deviation emerges as
∆SeCRS A = ∆SeCRS A +
ηSeZ2ξ + (1 − η)(1− SpZ2)ε
P (ZCRS A = 1)
.(28)
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As for the specificity, under the HCI,
SpCRS AX =
η(1− SeX)(1− SeZ1SeZ2) + (1− η)SpX(SpZ1 + SpZ2 − SpZ1SpZ2)
P (ZCRS A = 0)
,(29)
hence, the specificity deviation emerges as
∆SpCRS A = −η(1− SeZ1SeZ2)(SeX + SpX − 1)
P (ZCRS A = 0)
(30)
= −η(1− SeZ1SeZ2)JX
P (ZCRS A = 0)
.
In the case of local dependence as defined by (7),
SpCRS AX = Sp
CRS A
X +
ηSeZ2ξ + (1 − η)(1− SpZ2)ε
P (ZCRS A = 0)
,(31)
whereby the Sp deviation becomes
∆SpCRS A = ∆SpCRS A +
ηSeZ2ξ + (1− η)(1 − SpZ2)ε
P (ZCRS A = 0)
.(32)
Just as described earlier for IGS, the deviations ∆SeCRS A and ∆SpCRS A, in (28) and (32), have two
components: one reflecting the method’s imperfection, shared with the HCI case, and a second one expressing
the conditional dependence. The first component is non-positive (since it would be unreasonable to conceive
JX < 0), contributing to the Se and Sp underestimation (except for a few cases of null bias). The second
component, which is due to local dependence, may be either negative or positive, depending on the conditional
covariances, ξ and ε. Hence, the local dependence effect may contribute either to reinforce or cancel the
effect of the CRS A imperfection.
4.2. Composite Reference Standard - “or” rule. We admit that ZCRS O is a binary variable that
expresses the results of combining two diagnostic tests, Z1 and Z2, using the “or” rule, which means that
ZCRS O is positive if any of the tests, Z1 or Z2, is positive, and Z
CRS O is negative otherwise, i.e., if both
tests are negative. It follows that
(33) ZCRS O =
{
1, if (Z1 = 1 ∨ Z2 = 1)
0, if (Z1 = 0 ∧ Z2 = 0),
and consequently
P (ZCRS O = 1) = η(SeZ1 + SeZ2 − SeZ1SeZ2) + (1− η)(1 − SpZ1SpZ2) and(34)
P (ZCRS O = 0) = 1− P (ZCRS O = 1).
Assuming that the HCI is valid,
SeCRS OX =
ηSeX(SeZ1 + SeZ2 − SeZ1SeZ2) + (1− η)(1 − SpX)(1− SpZ1SpZ2)
P (ZCRS O = 1)
,(35)
and the Se deviation is given by
∆SeCRS O = − (1− η)(1 − SpZ1SpZ2)(SeX + SpX − 1)
P (ZCRS O = 1)
.(36)
= − (1− η)(1 − SpZ1SpZ2)JX
P (ZCRS O = 1)
.
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Admitting the dependence structure in (7) leads to
SeCRS OX = Se
CRS O
X +
η(1− SeZ2)ξ + (1− η)SpZ2ε
P (ZCRS O = 1)
,(37)
and the corresponding Se deviation is
∆SeCRS O = ∆SeCRS O +
η(1− SeZ2)ξ + (1− η)SpZ2ε
P (ZCRS O = 1)
.(38)
Regarding the Sp, assuming the HCI, we have
SpCRS OX =
η(1− SeX)(1− SeZ1)(1 − SeZ2) + (1− η)SpXSpZ1SpZ2
P (ZCRS O = 0)
,(39)
and the specificity deviation
∆SpCRS O = −η(1− SeZ1)(1− SeZ2)(SeX + SpX − 1)
P (ZCRS O = 0)
(40)
= −η(1− SeZ1)(1− SeZ2)JX
P (ZCRS O = 0)
.
As for the Sp under the dependence structure presumed in (7),
SpCRS OX = Sp
CRS O
X +
η(1− SeZ2)ξ + (1− η)SpZ2ε
P (ZCRS O = 0)
,(41)
and the Sp deviation arises as
∆SpCRS O = ∆SpCRS O +
η(1− SeZ2)ξ + (1− η)SpZ2ε
P (ZCRS O = 0)
.(42)
Once again the deviations under local dependence, ∆SeCRS O and ∆SpCRS O in (38) and (42), comprise
two terms, one corresponding to the method’s imperfection and one to local dependence. The term expressing
the effect of CRS O leads to underestimation of either Se or Sp (except for the few cases of null bias), while
the effect of local dependence may be either negative or positive, whereby the two effects may reinforce or
cancel each other.
5. Discrepant analysis
In discrepant analysis, the test whose performance we aim to evaluate, X , is initially compared with an
imperfect diagnostic test, Z1. If both tests agree, the corresponding result is assumed correct, but if the two
tests disagree, another test, called arbiter or resolver test, Z2, is performed to resolve the discrepancy. The
result of applying DA is expressed by the binary variable ZDA:
(43) ZDA =

1 if (X = 1 ∧ Z1 = 1)∨
(X = 1 ∧ Z1 = 0 ∧ Z2 = 1) ∨ (X = 0 ∧ Z1 = 1 ∧ Z2 = 1)
0 if (X = 0 ∧ Z1 = 0)∨
(X = 0 ∧ Z1 = 1 ∧ Z2 = 0) ∨ (X = 1 ∧ Z1 = 0 ∧ Z2 = 0).
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Under the HCI, we have the following joint probabilities
PHCI(X = 1, Z1 = 1) = ηSeXSeZ1 + (1− η)(1 − SpX)(1 − SpZ1),
PHCI(X = 1, Z1 = 0, Z2 = 1) = ηSeX(1 − SeZ1)SeZ2 + (1− η)(1 − SpX)SpZ1(1− SpZ2),
PHCI(X = 0, Z1 = 1, Z2 = 1) = η(1− SeX)SeZ1SeZ2 + (1− η)SpX(1− SpZ1)(1 − SpZ2),
which add up to obtain
P (ZDA = 1) = PHCI(X = 1, Z1 = 1) + P
HCI(X = 1, Z1 = 0, Z2 = 1) + P
HCI(X = 0, Z1 = 1, Z2 = 1).
The Se according to DA is given by
SeDAX =
PHCI(X = 1, Z1 = 1) + P
HCI(X = 1, Z1 = 0, Z2 = 1)
P (ZDA = 1)
,(44)
and the sensitivity deviation is
∆SeDA =
(1− SeX)
[
PHCI(X = 1, Z1 = 1) + P
HCI(X = 1, Z1 = 0, Z2 = 1)
]
P (ZDA = 1)
(45)
− SeXP
HCI(X = 0, Z1 = 1, Z2 = 1)
P (ZDA = 1)
.
Under the HCI violation in Eq. (7), we have
PHCI(X = 1, Z1 = 1) = P
HCI(X = 1, Z1 = 1) + ηξ + (1− η)ε,
PHCI(X = 1, Z1 = 0, Z2 = 1) = P
HCI(X = 1, Z1 = 0, Z2 = 1)− ηSeZ2ξ − (1 − η)(1− SpZ2)ε,
PHCI(X = 0, Z1 = 1, Z2 = 1) = P
HCI(X = 0, Z1 = 1, Z2 = 1)− ηSeZ2ξ − (1 − η)(1− SpZ2)ε,
and then
P (ZDA = 1) = P (ZDA = 1) + η(1− 2SeZ2)ξ − (1 − η)(1− 2SpZ2)ε.
Accordingly, we obtain
SeDAX =
PHCI(X = 1, Z1 = 1) + P
HCI(X = 1, Z1 = 0, Z2 = 1)
P (ZDA = 1)
,(46)
and the sensitivity deviation ∆SeDA emerges as
∆SeDA =
(1− SeX)
[
PHCI(X = 1, Z1 = 1) + P
HCI(X = 1, Z1 = 0, Z2 = 1)
]
P (ZDA = 1)
(47)
− SeXP
HCI(X = 0, Z1 = 1, Z2 = 1)
P (ZDA = 1)
.
In the case of specificity, under the HCI, we obtain the expression
SpDAX =
PHCI(X = 0, Z1 = 0) + P
HCI(X = 0, Z1 = 1, Z2 = 0)
P (ZDA = 0)
,(48)
given that
PHCI(X = 0, Z1 = 0) = η(1− SeX)(1 − SeZ1) + (1− η)SpXSpZ1 ,
PHCI(X = 0, Z1 = 1, Z2 = 0) = η(1− Se(X))SeZ1(1− SeZ2) + (1− η)SpX(1− SpZ1)SpZ2 ,
PHCI(X = 1, Z1 = 0, Z2 = 0) = ηSeX(1− SeZ1)(1 − SeZ2) + (1− η)(1 − SpX)SpZ1SpZ2 ,
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and also
P (ZDA = 0) = 1− P (ZDA = 1).(49)
Therefore, the specificity deviation is
∆SpDA =
(1− SpX)
[
PHCI(X = 0, Z1 = 0) + P
HCI(X = 0, Z1 = 1, Z2 = 0)
]
P (ZDA = 0)
(50)
− SpXP
HCI(X = 1, Z1 = 0, Z2 = 0)
P (ZDA = 0)
.
Admitting the local dependence described in (7), we then have the following probabilities
PHCI(X = 0, Z1 = 0) = P
HCI(X = 0, Z1 = 0) + ηξ + (1− η)ε,
PHCI(X = 0, Z1 = 1, Z2 = 0) = P
HCI(X = 0, Z1 = 1, Z2 = 0)− η(1− SeZ2)ξ − (1− η)SpZ2ε,
PHCI(X = 1, Z1 = 0, Z2 = 0) = P
HCI(X = 1, Z1 = 0, Z2 = 0)− η(1− SeZ2)ξ − (1− η)SpZ2ε,
and also
P (ZDA = 0) = 1− P (ZDA = 1)(51)
Hence SpDAX emerges as
SpDAX =
PHCI(X = 0, Z1 = 0) + P
HCI(X = 0, Z1 = 1, Z2 = 0)
P (ZDA = 0)
.(52)
Additionally, ∆SpDA, is given by:
∆SpDA =
(1− SpX)
[
PHCI(X = 0, Z1 = 0) + P
HCI(X = 0, Z1 = 1, Z2 = 0)
]
P (ZDA = 0)
(53)
− SpXP
HCI(X = 1, Z1 = 0, Z2 = 0)
P (ZDA = 0)
.
Unlike IGS, CRS A or CRS O, in the case of DA, SeDAX , Sp
DA
X , and the corresponding deviations, ∆Se
DA
and ∆SpDA, do not comprise separate terms for the method’s imperfection and for the dependence effect. As
a matter of fact, the conditional covariances, ξ and ε, are not confined to a detached term in the formulas, but
appear both in the numerator and denominators of (46), (47), (52), and (53), combined with the expressions
present in the formulas derived for the DA under HCI.
6. A unified approach for IGS, CRS A, CRS O, and DA
Methods CRS A, CRS O, and DA can be seen as special cases of IGS. Indeed, it is possible to express each
method M ∈ {CRS A,CRS O,DA} by means of an IGS, represented by Z˜M in Table 1. The reformulated
conditional covariances, ξ˜M = cov(X, Z˜M|Y = 1) and ε˜M = cov(X, Z˜M|Y = 0) are included in the same
table. Approaching each method M as an IGS, the derivations developed in Sections 4 and 5, may be
simpler if the SeMX , Sp
M
X , ∆Se
M, and ∆SpM, as well as the corresponding expressions for the HCI violation,
are derived as special cases of (14) through (22). Moreover, the unification of this group of methods covered
in our work, all of which rely on comparisons with imperfect references, represents a unified way of studying
their deviations.
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Table 1. Correspondence between the methods M ∈ {CRS A,CRS O,DA} covered in our
work and the IGS.
M Z˜M ξ˜M ε˜M
IGS Z1 ξ ε
CRS A Z1Z2 −ξ(1− SeZ2) −εSpZ2
CRS O 1− (1 − Z1)(1− Z2) ξ(1 − SeZ2) εSpZ2
DA XZ1 +X(1− Z1)Z2 + (1 −X)Z1Z2 ξ˜DA (1) ε˜DA (1)
(1) Lengthy expressions omitted from the table. Vide (54) and (55), respectively, for ξ˜DA and ε˜DA.
ξ˜DA = SeX(1− SeX)
[
SeZ1 + SeZ2(1− 2SeZ1)
]
+ ξ(1 − SeX − SeZ2 + 2SeXSeZ2).(54)
ε˜DA = SpX(1− SpX)
[
SpZ1 + SpZ2(1− 2SpZ1)
]
+ ε(1− SpX − SpZ2 + 2SpXSpZ2).(55)
Furthermore, this approach makes clear, by the expression obtained for Z˜DA, that, in the case of DA, the
index test X is used to define the reference against which X itself is evaluated. This participation of the
test under evaluation in the construction of the reference has been pointed as one of the major drawbacks
of DA [e.g., 22, 25]. It is also due to the inclusion of X in Z˜DA that, unlike the other methods in Table 1,
it is not possible to express any of the deviations, ∆SeDA or ∆SpDA, in (47) and (53), as the sum of two
separate terms, one for the method’s imperfection and one for the dependence effect.
All the performance methods covered in our work lead to biased estimates of the accuracy measures
under various circumstances. Besides the insight we can gain towards a specific case, based on the Se and Sp
theoretical expressions, we can also derive certain generic conclusions. We summarise some of these findings,
regarding IGS, CRS A, and CRS O, in Tables 2 and 3. The findings derived from the analytical expressions
of DA and LCM are not summarised in the same way due to the increased complexity of the expressions.
7. Latent class model
In the absence of a gold standard, latent class models are widely used to estimate diagnostic tests per-
formance measures, such as sensitivity and specificity, as well as the prevalence. In this context, a widely
used LCM admits a binary latent variable, Y , such as defined in Subsection 2.1, whose categories are called
latent classes and indicate the status regarding the condition of interest. Furthermore, the LCM admits
manifest variables Xi (i = 1, ..., p), that express the outcomes of p diagnostic tests, assuming the value
1 if the i-th diagnostic test is positive and 0 otherwise. The simplest LCM assumes the HCI previously
mentioned, which means that the test results are independent conditional on the status of the condition of
interest.
Given Sei = SeXi = P (Xi = 1|Y = 1), Spi = SpXi = P (Xi = 0|Y = 0), with i = 1, 2, 3, and η = P (Y = 1),
then, for p = 3, we have
(56) P (X1 = x1, X2 = x2, X3 = x3) = η
3∏
j=1
Se
xj
j (1− Sej)1−xj + (1 − η)
3∏
j=1
Sp
1−xj
j (1− Spj)xj .
The setup defined in Subsection 2.2, and used throughout the paper, is transposable to the LCM context,
if we admit that the tests Xi (i = 1, ..., 3) correspond, respectively, to the test under study, X , and to the
imperfect diagnostic tests, Z1 and Z2.
Next we will present analytical expressions for Sei, Spi, and η corresponding to the LCM under the HCI, as
discussed in the literature [31, 45].
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Table 2. Summary of the findings on the Se deviations for the methods IGS, CRS A, and CRS O.
HCI HCI violation
Methods ∆SeM ≤ 0 ∆SeM = 0 Monotony: ∆SeM ց if (2) (3) ∆SeM ≤ ∆SeM ∆SeM ≥ 0
IGS Always
SpZ1 = 1
∨
JX = 0 ∨ η = 1 (4)
• SeX ր
• SpX ր
• SeZ1 ց
• SpZ1 ց
• η ց
ηξ + (1− η)ε ≤ 0 ηξ + (1 − η)ε≥
(1− η)(1 − SpZ1)JX
CRS A Always
SpZ1 = 1 ∨ SpZ2 = 1
∨
JX = 0 ∨ η = 1 (4)
• SeX ր
• SpX ր
• SeZ1 ց
• SpZ1 ց
• SeZ2 ց
• SpZ2 ց
• η ց
ηSeZ2ξ + (1− η)(1 − SpZ2)ε ≤ 0
ηSeZ2ξ + (1− η)(1 − SpZ2)ε
≥
(1 − η)(1− SpZ1)(1 − SpZ2)JX
CRS O Always
SpZ1 = 1 ∧ SpZ2 = 1
∨
JX = 0 ∨ η = 1 (4)
• SeX ր
• SpX ր
• SeZ1 ց
• SpZ1 ց
• SeZ2 ց
• SpZ2 ց
• η ց
η(1− SeZ2)ξ + (1− η)SpZ2ε ≤ 0
η(1 − SeZ2)ξ + (1− η)SpZ2ε
≥
(1− η)(1 − SpZ1SpZ2)JX
(2) The symbol ց refers to “decreasing” and ր to “increasing”.
(3) Any of the listed conditions contributes to decrease ∆SeM (∆SeM ց).
(4) JX = 0 and η = 1 are unreasonable conditions, since JX = 0 implies a valueless index test, and η = 1,
i.e., a prevalence of one, means that every subject in the population has the target condition. In fact, we
assume JX > 0 and η ∈]0, 1[.
Let us define
p123 = P
HCI(X1 = 1, X2 = 1, X3 = 1) = ηSe1Se2Se3 + (1− η)(1 − Sp1)(1 − Sp2)(1 − Sp3),(57)
pi = P
HCI(Xi = 1) = ηSei + (1− η)(1 − Spi),
pij = P
HCI(Xi = 1, Xj = 1) = ηSeiSej + (1− η)(1 − Spi)(1− Spj),
aij = pij − pipj, with i 6= j, and i, j = 1, 2, 3,
V =
p123 − p12p3 − p13p2 − p23p1 + 2p1p2p3√
a12a13a23
.
For the sensitivities, we have
SeLCMi = pi +
√
aijaik
ajk
√
1− η
η
,(58)
where i 6= j, i 6= k, j 6= k, and i, j, k = 1, 2, 3,
and for the specificities,
SpLCMi = 1− pi +
√
aijaik
ajk
√
η
1− η .(59)
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Table 3. Summary of the findings on the Sp deviations for the methods IGS, CRS A, and CRS O.
HCI HCI violation
Methods ∆SpM ≤ 0 ∆SpM = 0 Monotony: ∆SpM ց if (5) ∆SpM ≤ ∆SpM ∆SpM ≥ 0
IGS Always
SeZ1 = 1
∨
JX = 0 ∨ η = 0 (6)
• SeX ր
• SpX ր
• SeZ1 ց
• SpZ1 ց
• η ր
ηξ + (1− η)ε ≤ 0
ηξ + (1 − η)ε
>
(1− η)(1 − SpZ1)JX
CRS A Always
SeZ1 = 1 ∧ SeZ2 = 1
∨
JX = 0 ∨ η = 0 (4)
• SeX ր
• SpX ր
• SeZ1 ց
• SpZ1 ց
• SeZ2 ց
• SpZ2 ց
• η ր
ηSeZ2ξ + (1 − η)(1− SpZ2)ε ≤ 0
ηSeZ2ξ + (1− η)(1 − SpZ2)ε
>
η(1 − SeZ1SeZ2)JX
CRS O Always
SeZ1 = 1 ∨ SeZ2 = 1
∨
JX = 0 ∨ η = 0 (4)
• SeX ր
• SpX ր
• SeZ1 ց
• SpZ1 ց
• SeZ2 ց
• SpZ2 ց
• η ր
η(1− SeZ2)ξ + (1− η)SpZ2ε ≤ 0
η(1 − SeZ2)ξ + (1− η)SpZ2ε
>
η(1 − SeZ1)(1− SeZ2)JX
(5) Any of the listed conditions contributes to decrease ∆SpM (∆SpM ց).
(6) JX = 0 and η = 0 are unreasonable conditions, since JX = 0 implies a valueless index test, and η = 0,
i.e., a prevalence of zero, means that no subject in the population has the target condition. In fact, we
assume JX > 0 and η ∈]0, 1[.
Regarding the two preceding expressions, (58) and (59), in each case the expression presented is chosen
between two solutions. For example, we have SeLCMi = pi±
√
aijaik
ajk
√
1−η
η
. The choice follows the reasonable
assumption that the true positive-rate is at least as large as the false positive rate, i.e., Sei ≥ (1− Spi) [31].
It follows that
ηLCM =
1
2
±
√
1
4
− 1
4 + V 2
,(60)
and between these two solutions, the most commonly used is ηLCM = 12 −
√
1
4 − 14+V 2 , since η < 0.5 in most
practical situations.
We derived similar expressions under the HCI violation as defined in (7). Let us recall that we denote
ξ = cov(X1, X2|Y = 1) = cov(X,Z1|Y = 1) and ε = cov(X1, X2|Y = 0) = cov(X,Z1|Y = 0). We will add
the subscript HCI to indicate that a certain expression concerns the HCI violation case.
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In this context,
PHCI(X1 = 1, X2 = 1|Y = 1) = Se1Se2 + ξ,
PHCI(X1 = 1, X2 = 1|Y = 0) = (1− Sp1)(1− Sp2) + ε,
PHCI(X1 = 1, X2 = 1, X3 = 1|Y = 1) = Se1Se2Se3 + Se3ξ,
PHCI(X1 = 1, X2 = 1, X3 = 1|Y = 0) = (1− Sp1)(1− Sp2)(1− Sp3) + (1− Sp3)ε.
Based on these reformulated expressions and given the formulas in (57), we obtain:
pHCI123 = p123 + ηSe3ξ + (1− η)(1 − Sp3)ε,(61)
pHCI12 = p12 + ηξ + (1− η)ε,
pHCIi3 = pi3, , because Xi⊥⊥ X3 | Y = y, with y = 0, 1, for i = 1, 2,
pHCIi = pi, i = 1, 2, 3.
Under the HCI violations, the sensitivities2 emerge as
SeLCM1 = p1 +
√(1− η
η
)a12a13
a23
− (1− η)a13
a23
ξ − (1− η)
2
η
a13
a23
ε,(62)
SeLCM2 = p2 +
√(1− η
η
)a23a12
a13
− (1− η)a23
a13
ξ − (1− η)
2
η
a23
a13
ε,(63)
SeLCM3 = p3 +
√(1− η
η
) a13a23
a12 − ηξ − (1 − η)ε .(64)
From the expression for pi (i = 1, 2, 3), among Equations (57), which is valid both under the HCI and under
its violation, we can establish the following relation between Spi and Sei
Spi = 1−
1
1− η (pi − ηSei).(65)
It follows that the specificities according to the LCM under HCI violation are given by
SpLCM1 = 1− p1 +
√( η
1− η
)a12a13
a23
− η
2
1− η
a13
a23
ξ − η a13
a23
ε,(66)
SpLCM2 = 1− p2 +
√( η
1− η
)a12a23
a13
− η
2
1− η
a23
a13
ξ − η a23
a13
ε,(67)
SpLCM3 = 1− p3 +
√( η
1− η
) a13a23
a12 − ηξ − (1− η)ε .(68)
Introducing the expressions (58) and (59), obtained for SeLCMi and Sp
LCM
i , with i = 1, 2, 3, into the expression
(61), derived for pLCM123 leads to
pLCM123 = p1p2p3
(
1 + a12 + a23 + a13 +
√
a12a13a23
{√1− η
η
−
√
η
1− η
})
+ ηSe3ξ + (1 − η)(1− Sp3)ε.
(69)
2Here we present only one of the two possible solutions, based on the rationale previously explained.
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If we define
V1 = p
LCM
123 − p1p2p3(1 + a12 + a23 + a13),(70)
V2 = p1p2p3
√
a12a13a23.(71)
then we obtain the expression
V2
{√1− η
η
−
√
η
1− η
}
+ ηp3(ξ − ε) +
√
η(1− η) a13a23
a12 − ηξ − (1− η)ε (ξ − ε) = V1 − p3ε.(72)
If we admit ξ = ε, i.e., cov(X,Z1|Y = 1) = cov(X,Z1|Y = 0), which means that the conditional covariances
between X and Z1 are the same, then the previous expression simplifies into
V2
{√1− η
η
−
√
η
1− η
}
= V1 − p3ε,(73)
leading to
η =
1
2
±
√
1
4
− 1
4 +W 2
, where W =
V1 − p3ε
V2
.(74)
As explained earlier in the text, since typically η < 0.5 , we opt for the solution
ηLCM =
1
2
−
√
1
4
− 1
4 +W 2
.(75)
Latent class models yield unbiased estimates of the parameters when the underlying assumptions hold,
which means that the LCM Se and Sp expressions derived earlier lead to the true population parameters
and no deviations can be quantified, when the population and the LCM coincide regarding the dependence
structure. In order to evaluate potential deviations arising from the use of LCM, we model situations in
which an incorrect LCM for a specific population is applied. In fact, we admit two scenarios:
(1) LCM under HCI is used, although this assumption is invalid in the population, which verifies local
dependence according to (7). This scenario, which we designate LCM(HCI), summarises situations
where the population features conditional dependencies between the index test and one of the im-
perfect references, which are ignored by the model adjusted to the data, since the LCM assumes the
HCI. Hence, in this case we quantify the effect of using the LCM incorrectly assuming the HCI.
(2) LCM assuming the violation of HCI, as defined in (7), is adopted, although conditional independence
between the tests is valid in the population. This scenario, denominated LCM(HCI), addresses a
situation where an unnecessary complex model is adjusted to the population. Indeed, the HCI is valid
in the population, but the model introduces two unnecessary parameters, ξ = cov(X1, X2|Y = 1)
and ε = cov(X1, X2|Y = 0), to model nonexistent local dependencies.
The complexity of the Se and Sp expressions makes it difficult to understand how these vary with the
prevalence, diagnostic accuracy measures, and dependencies between the tests. In order overcome this prob-
lem and identify Se and Sp patterns of variation, deviations for specific values with practical relevance can
be calculated and visualised using an R Shiny application made available online to the reader.
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8. Admissible values for the conditional covariances
The parameters ξ and ε model local dependencies between the diagnostic test X and one of the imperfect
reference tests, Z1. In this Section, we report the ranges of acceptable values for ξ and ε required by the
different methods and cases covered in the paper.
For a start, we must ensure that the values of ξ and ε lead to 0 ≤ P (X,Z1|Y = y) ≤ 1, with y = 0, 1.
Thus, regardless of the method M, assuming the violation of HCI in the population, we must impose
max(−SeXSeZ1 ,−(1− SeX)(1 − SeZ1)) ≤ ξ ≤ min(SeX , SeZ1)− SeXSeZ1 , and(76)
max(−SpXSpZ1 ,−(1− SpX)(1− SpZ1)) ≤ ε ≤ min(SpX , SpZ1)− SpXSpZ1 .
For the particular case of the LCM, the analytical expressions for Se, Sp, and η may lead to values that lie
outside the admissible interval [0, 1], a problem previously reported in the literature [e.g., 45]. To workaround
this difficulty, instead of restricting the values of ξ and ε to ranges for which the theoretical expressions lie
within [0, 1], we impose SeLCMi = min(Se
LCM
i , 1) ∧ SeLCMi = max(SeLCMi , 0), with i = 1, 2, 3, and force the
same for Sp and η, for the LCM both under the HCI and the HCI violation.
When the population and the LCM do not match regarding the HCI, corresponding to the scenarios
LCM(HCI) and LCM(HCI), defined in Section 7, additional restrictions on ξ and ε are needed. In fact, the
analytical expressions of Se, Sp, and η according to the LCM include square roots, whose radicands must
be non-negative. Specifically for LCM(HCI) and LCM(HCI), in order to have non-negative radicands in the
analytical formulas, the values of ξ and ε must verify the conditions:
ηξ + (1− η)ε ≥ −η(1− η)(1 − Se1 − Sp1)(1 − Se2 − Sp2), for LCM(HCI), and(77)
ηξ + (1− η)ε ≤ η(1 − η)(1− Se1 − Sp1)(1− Se2 − Sp2), for LCM(HCI).
In the R Shiny application, for every set of parameters specified by the user, the valid limits of ξ and ε
are calculated, and the plots reflect these changes. In some situations, the ranges of possible values for the
different methods do not coincide, whereby the various methods represented in the same plot may correspond
to different ranges of values in the horizontal axis.
9. Se and Sp deviations motivated by a practical problem
We now illustrate the practical utility of the theoretical results, by examining the deviations determined
for a particular setting, defined by a list of sensitivities and specificities for the three diagnostic tests (X ,
Z1, and Z2), prevalence of the condition, η, and conditional covariances, ξ and ε. Besides these fixed values,
realistic variation intervals, that mimic the researcher’s uncertainty about the parameters, are also proposed.
It is then possible to investigate the effect of factors we deem relevant (accuracy of the tests, prevalence,
and conditional dependence between the tests) on ∆SeM and ∆SpM, by varying the factors within ranges of
plausible values.
The fixed values and variation intervals were chosen according to studies concerning C. Trachtomatis or
infectious diseases such as tuberculosis or pneumonia (see [43] and references therein). Hence, we admit the
following fixed populational values:
• Equal Se and Sp for the index test, SeX = SpX = 0.90;
• Equal Se for both imperfect reference tests, SeZ1 = SeZ2 = 0.60;
• Equal Sp for both imperfect reference tests, SpZ1 = SpZ2 = 0.95;
• Prevalence, η = 0.10.
As for the variation intervals, we presume the following intervals of plausible values:
• SeZ1 = SeZ2 take values in (0.30, 0.90), a wide range of values, spanning from low to high sensitivities;
• SpZ1 = SpZ2 vary within (0.90, 1), i.e., we admit high values for the specificities;
• Prevalence η assumes values in (0.05, 0.30), corresponding to low prevalences;
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• Conditional covariances range from ξ = ε = 0, corresponding to the HCI, to strong conditional
dependence, with ξ and ε assuming both positive and negative values within the range of values
acceptable according to (76) and (77).
In Subsection 9.1 we study the Se and Sp deviations in the case of conditionally independent tests.
The methods IGS, CRS A, CRS O, and DA are addressed. The deviations in the context of conditionally
dependent tests are investigated in Subsection 9.2, in which case the LCM assuming the HCI is also addressed.
Finally, in Subsection 9.3, we explore the deviations resulting from the use of LCM assuming inappropriate
dependence structures, i.e., LCM(HCI) and LCM(HCI).
9.1. Deviations under the HCI. Figure 1 presents the plots of the deviations ∆SeM and ∆SpM, for the
M methods IGS, CRS O, CRS A, and DA, varying with the Se and Sp of the imperfect reference test Z1,
and also with the prevalence, assuming local independence between the tests (ξ = ε = 0). These plots show
that:
• Sp deviations, ∆SpM, tend to be slimmer than Se deviations, ∆SeM, (Figure 1, right plots against
left, noting the differences in y-axis scales), implying smaller bias in Sp estimation than Se;
• ∆Sp vary slightly more with the prevalence, η, (Figure 1 (f)), than with the accuracy of the reference
Z1, SeZ1 and SpZ1 (Figure 1 (b) and (d));
• Figure 1 (a), (c), and (e) show that Se deviations are always negative for the IGS, CRS O, and
CRS A. The Se according to these three methods approach the true Se, as SeZ1 or SpZ1 increases;
• On the contrary, ∆SeDA assume positive values and slightly decrease with SeZ1 (Figure 1 (a)), but
thinly increase with SpZ1 and η (Figure 1 (c) and (e));
• As expected, the absolute value of the Se deviations, except for ∆SeDA, decrease with the prevalence
(Figure 1 (e)) and the absolute value of the Sp deviations increase (Figure 1 (f)).
• ∆SeDA range from values near 0.02 to 0.05, while ∆SeCRS A span from approximately −0.09 to
−0.01. Thus, for this particular setting, CRS A and DA seem preferable methods to estimate the
Se under HCI;
• Regarding the Sp, however, CRS A leads to estimates farther away from the true Sp, while DA and
CRS O based Sp are nearer the target (Figure 1 (b), (d), and (f)).
Based on the theoretical deviations presented in Figure 1, we aim to determine which method is preferable.
We start with ∆SeM under the HCI (Figure 1 (a), (c), (e)):
• DA overestimates SeX , while the remaining methods underestimate.
• Both CRS O and IGS strongly underestimate SeX . CRS O is the worst of the two, except for
SeZ1 ∈ [0.3, 0.4], in which case the IGS leads to estimates farther away from SeX .
• By contrast, CRS A and DA are the methods that produce estimates closer to the truth, although
CRS A underestimates the SeX , while DA overestimates.
Furthermore, we can compare CRS A and DA, which are the best methods for Se estimation in this case,
based on the effect of the different factors we explored:
• ∆SeM vs. SeZ1 (Figure 1 (a)): As SeZ1 increases, both |∆SeCRS A| and |∆SeDA| decrease. For
all values of SeZ1 , |∆SeDA| < |∆SeCRS A|, i.e., DA leads to estimates closer to the true SeX . DA
is noticeable better than CRS A, for lower values of SeZ1 , but for higher values of SeZ1 , the two
methods lead to deviations from SeX similar in absolute value, even if DA overestimates and CRS A
underestimates SeX .
• ∆SeM vs. SpZ1 (Figure 1 (c)): The curves of ∆SeCRS A and ∆SeDA plotted against SpZ1 have both
positive slope. Given that ∆SeDA > 0, it follows that the overestimation of SeX increases with
SpZ1 , i.e., the estimates get farther away from the true SeX . By contrast, since ∆Se
CRS A < 0, then
CRS A leads to estimates of SeX closer to the true values as SpZ1 increases. Accordingly, DA is
preferable to CRS A for lower values of SpZ1 and vice versa.
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Figure 1. Plots of ∆SeM (left panel, (a), (c), (e)) and ∆SpM (right panel, (b), (d), (f))
versus SeZ1 (upper panel, (a) and (b)), SpZ1 (middle panel, (c) and (d)), and the prevalence
η (lower panel, (e) and (f)), assuming the HCI. The methods M under comparison are IGS
(solid black line), CRS O (dashed red line), CRS A (dotted green line), and DA (dashed-
dotted blue line).
• ∆SeM vs. η (Figure 1 (e)): The variation of ∆SeCRS A and ∆SeDA against η is similar to the
pattern described in the preceding item for the variation against SpZ1 . Accordingly, we can replicate
the previous comments, stating that DA delivers better estimates of SeX for lower prevalences and
CRS A for higher.
We now explore the case of ∆SpM under the HCI (Figure 1 (b), (d), (f)):
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• The relative ordering of the curves replicates the one obtained for the ∆SeM. However, in this case,
∆SpM < 0 for all the methods, including DA, which assumes negative values except for SeZ1 > 0.75
or η < 0.06.
• The two best methods for SpX estimation in this case are DA and CRS O.
Regarding the impact of SeZ1 , SpZ1 , and η, we notice that DA leads to SpX estimates closer to the true
value, with the following exceptions:
• CRS O is better than DA for SeZ1 > 0.88, although the difference is of the order of magnitude of
10−3 (Figure 1 (b)).
• CRS O is slightly better for η < 0.03 (Figure 1 (f)).
In conclusion, combining the findings reached for ∆SeM and ∆SpM, DA is the method that leads to better
results, except for some limited cases.
9.2. Deviations under the violation of HCI. Figure 2 shows the plots of the deviations ∆SeM and ∆SpM
varying with the conditional covariances, ξ and ε, for the methods M, which are IGS, CRS A, CRS O, DA,
and the LCM assuming the HCI, when this assumption does not hold in the population, i.e., scenario
LCM(HCI). Both positive and negative local dependencies are investigated, ergo ξ and ε may assume
either positive or negative values. When the conditional covariance in one of the classes varies, conditional
independence is assumed in the other class, which means that, when we plot ∆SeM and ∆SpM against ξ, we
admit ε = 0, and vice versa. In the plots of Figure 2 we notice that:
• The slopes of the lines are systematically positive in the four plots, except for the ∆SeLCM(HCI), with
positive slopes for lower values of ε, but zero slope for higher values (Figure 2 (c)), as a result of
truncation due to the constraint Se
LCM(HCI)
X ≤ 1, resulting in ∆SeLCM(HCI) ≤ 0.1, since SeX = 0.90.
• Since the slopes of the deviations are positive, increasing ξ or ε leads to SeMX and SpMX closer to the
true values if the deviations are negative (e.g., IGS in Figure 2 (a)), and SeMX and Sp
M
X farther away
from the true values if the deviations are positive (e.g., DA in Figure 2 (b)).
• ∆SpM varies little with ξ for all the methods (Figure 2 (b)), and more with ε, except for CRS A,
almost unaffected by the changes of ε, as well as ξ (Figure 2 (d)).
• The slopes corresponding to ∆SpM against ξ are similar for all the methods (Figure 2 (b)), and also
for ∆SpM against ε, with the exception of CRS A (Figure 2 (d)).
• Steeper deviations are perceived for ∆SeM than for ∆SpM (Figure 2 (a) and (c) against (b) and (d),
which have different y-axis scales).
• The changes in ξ have a smaller effect in ∆SeM than the changes in ε, except for CRS A (Figure 2
(a) against (c)).
• CRS A, IGS, and LCM(HCI) are the methods which show larger variations of ∆SeM against ξ
(Figure 2 (a)).
• The largest variations of ∆SeM with ε (Figure 2 (c)) are again obtained for IGS and LCM(HCI),
but, in contrast with the previous case, for CRS O.
As far as the violation of HCI goes, let us compare the methods in more detail, based on the variation of
∆SeM and ∆SeM with ξ, under the assumption ε = 0 (Figure 2 (a), (b)):
• Same as under the HCI, DA is the best method in some cases (ξ < −0.032). CRS A is preferable
for ξ > 0.021, and for values of ξ in between LCM(HCI) gives estimates of SeX closer to the true
values.
• LCM(HCI) estimates SpX slightly better than the remaining methods for all the valid values of ξ,
other than ξ > 0.03, in which case DA dimly surpasses LCM(HCI).
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Figure 2. Plots of ∆SeM (left panel, (a) and (c)) and ∆SpM (right panel, (b) and (d))
versus the conditional covariances, ξ = cov(X,Z1|Y = 1) (upper panel, (a) and (b)) and
ε == cov(X,Z1|Y = 0) (lower panel, (c) and (d)). The methods M under comparison are
IGS (solid black line), CRS O (dashed red line), CRS A (dotted green line), DA (dashed-
dotted blue line), and LCM(HCI) (long-dashed purple line).
• Combining the results obtained for the estimation of SeX and SpX , we can argue that LCM(HCI)
is preferable for almost all values of ξ, despite the impact of ξ on the LCM(HCI) estimates.
Comparing the methods regarding the effect on ∆SeM and ∆SpM of ε, under the assumption ξ = 0 (Fig-
ure 2 (c), (d)):
• The estimation of SeX is considerably affected by the changing ε, for all the methods. Among these,
DA and CRS A are the ones that vary less.
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• CRS A is the only method that remains almost unchanged for different values of ε regarding the
estimation of SpX . All the other methods are clearly affected, underestimating SpX for lower values
of ξ and overestimating for higher values.
• For different ranges of ε, in turn, the methods LCM(HCI), DA, CRS O or IGS lead to estimates of
SpX closer to its true value.
• Taking into account both ∆SeM and ∆SpM against ε, it follows that LCM(HCI) is the best method
for lower values of ε, while IGS gives better results for higher values, and DA is preferable for a
certain range in between.
9.3. Deviations for LCM assuming invalid dependence structures. We explore the Se and Sp devi-
ations arising from the mismatch between the population and the LCM, in terms of conditional dependence
between the tests. As detailed earlier in the end of Section 7, we address the following two cases: (a) HCI
invalid in the population, but a LCM under HCI is used to model it, i.e., an overly simplistic model for
the population is adopted; (b) HCI valid in the population, but a LCM assuming conditional dependence
is used, i.e., an unnecessarily complex model is adopted. The first case is designated LCM(HCI), and the
second LCM(HCI).
Figure 3 exhibits the plots of the deviations ∆SeM and ∆SpM against the covariances ξ and ε, for
M ∈ {LCM(HCI),LCM(HCI)}. The plots in Figure 3 shows situations where conditional dependence in
presumed in only one of the classes at a time. In fact, when the variation of ξ is investigated, it is assumed
that ε = 0 (upper panel, (a) and (b)), while under the variation of ε, we have ξ = 0 (lower panel, (c) and
(d).
According to the plots in Figure 3:
• The changes in ε have a greater effect in ∆SeM and ∆SpM than the changes in ξ (Figure 3 (c) and
(d) against (a) and (b)), i.e., the effect is higher when the conditional dependence is introduced in
the class with highest frequency.
• The impact of varying the conditional covariance, whether ξ or ε, is greater in ∆SeM than ∆SpM
(Figure 3 (a) and (c) against (b) and (d)).
• LCM(HCI) and LCM(HCI) lead to deviations in opposite directions.
• For ξ < 0, as well as for ε < 0, LCM(HCI) leads to negative Se and Sp deviations, whereas
LCM(HCI) yields positive deviations. Inversely, for ξ > 0 or ε > 0, LCM(HCI) leads to positive Se
and Sp deviations, while LCM(HCI) results in negative deviations.
• The deviations are null if ξ = 0 in Figure 3, (a) and (b), or ε = 0 in Figure 3, (c) and (d),
corresponding to the case ξ = ε = 0 for both the population and the LCM, i.e., coherence between
the population and the LCM regarding the conditional dependence.
• ∆SeLCM(HCI) and ∆SeLCM(HCI) vs. ξ have similar absolute values in Figure 3 (a), just as ∆SpLCM(HCI)
and ∆SpLCM(HCI) vs. ξ have very close absolute values in Figure 3 (b).
• The Se and Sp deviations in Figure 3 (c) and (d) display slightly larger absolute values for LCM(HCI)
than for LCM(HCI), i.e., LCM(HCI) leads to Se and Sp deviations farther away from the true values
than LCM(HCI), for higher values of ε. In this case, the method that introduces inappropriate
conditional dependence when the HCI is valid in the population, i.e., a needlessly complex model,
leads to estimates farther away from the truth than the simplified model LCM(HCI).
10. Discussion
We propose a theoretical approach to investigate and compare some of the most undemanding and com-
monly used methods to evaluate the accuracy of a diagnostic test in the absence of a gold standard. We rely
on analytical expressions for the deviations between the sensitivity and specificity according to each method,
and the corresponding true values. The effect on these theoretical deviations of factors such as the tests
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Figure 3. Plots of ∆SeM (left panel, (a) and (c)) and ∆SpM (right panel, (b) and (d))
versus the conditional covariances ξ (upper panel, (a) and (b)) and ε (lower panel, (c) and
(d)). M ∈ {LCM(HCI),LCM(HCI)}, such that LCM(HCI) corresponds to applying a LCM
under HCI to a population with conditionally dependent tests, whereas LCM(HCI) stands
for the case in which a LCM assuming conditional dependence is adopted, but the HCI is
valid in the population.
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accuracy, prevalence, and conditional dependence between the tests may be explored and visualised through
the use of an interactive R Shiny application, made available online along with this article.
We believe that our approach is of great practical utility, in spite of its theoretical nature. In fact, the
researcher with a mere practical interest, may bypass the deduction of the mathematical expressions, and
simply explore the formulas to gain further insight into the methods. The R Shiny application allows the
user to perform a sensitivity analysis, studying the magnitude and direction of the deviations relevant for a
particular case of interest, based on ranges of values anticipated for the parameters. An additional merit of
this approach is the removal of the confounding effects arising from the sampling scheme.
The methods addressed in this work may be organised into two groups. On the one hand, IGS, CRS A,
CRS O, and DA form a set of methods that evaluate the index test’s accuracy based on the direct com-
parison with a single or multiple imperfect diagnostic tests. These methods can be simplified into a unified
formulation as an IGS. On the other hand, the LCM stands for a different approach, in which the model
combines results from multiple diagnostic tests to estimate the performance measures and the prevalence of
the condition.
DA stands out among the methods in the first group. Underlying DA is the intuitive idea whereby a
subset of the cases for which disagreement between the index test and the imperfect reference occurs, should
be subject to an additional reference test to validate the outcome. It follows that the index test itself
contributes to define the reference against which it is evaluated, a controversial strategy, harshly criticised in
the literature. DA estimates are obtained without correct model specification, since the singularities of the
DA procedure are omitted from the model. Imputation could prove promising to cope with this drawback
and improve DA estimates.
Regarding DA, we can also point out that it tends to overestimate the accuracy measures more frequently
than the remaining methods in the group. In the biomedical context, the ethical implications associated
with overestimating the accuracy measures are more serious than in the case of underestimation. However, if
the direction of the bias could be overlooked, and only the magnitude mattered, then DA could be preferable
in some cases, such as the one described in Subsection 9.1, when it provides closer estimates to the true
values than the other methods. These findings may be transposed to fields where DA is also applied, but
the overestimation of the performance is less alarming.
CRS and LCM emerge in the literature as two of the most promising methods to evaluate diagnostic tests
performance in the absence of a gold standard. An advantage of the CRS is that it offers the possibility
of incorporating previous available information on the tests. In fact, the CRS estimates improve when the
rule chosen to combine the tests follows from prior knowledge on their characteristics. The basic LCM does
not integrate this kind of preliminary information, but it is also feasible to do so in the context of LCM, by
introducing restrictions into the model or otherwise by adopting a Bayesian approach, whereby additional
information can be incorporated through prior informative distributions.
In our setup, we defined η as the prevalence of the condition of interest. However, in practice, the
experimental design may lead to samples that do not reflect the parent population regarding the prevalence.
Since Se and Sp deviations may vary considerably with η, the estimates obtained for these accuracy measures
may change with the sampling schemes and the corresponding proportions of individuals with the condition
in the sample.
As future work, we intend to generalise our approach to cases that are not covered in the present work.
Here we admit three diagnostic tests, but it would be pertinent to include more tests in the setup. Also,
other evaluation methods should be explored under a similar approach, namely latent class models with
random effects to accommodate conditional dependence between the tests, bayesian latent class models,
and imputation approaches to LCM. Moreover, if the complexity of some of these models undermines the
derivation of theoretical expressions for the Se and Sp deviations, the problem may be approached via a
simulation study.
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